Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer

The treatment of non-small cell lung cancer (NSCLC) has recently evolved with the introduction of targeted therapy based on the use of tyrosine kinase inhibitors (TKIs) in patients with certain gene alterations, including EGFR, ALK, ROS1, BRAF, and MET genes. Molecular targeted therapy based on TKIs...

Descripción completa

Detalles Bibliográficos
Autores principales: Buszka, Karolina, Ntzifa, Aliki, Owecka, Barbara, Kamińska, Paula, Kolecka-Bednarczyk, Agata, Zabel, Maciej, Nowicki, Michał, Lianidou, Evi, Budna-Tukan, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497234/
https://www.ncbi.nlm.nih.gov/pubmed/36139444
http://dx.doi.org/10.3390/cells11182871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497234/
https://www.ncbi.nlm.nih.gov/pubmed/36139444
http://dx.doi.org/10.3390/cells11182871

Ejemplares similares